(Q38544457)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26159048%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

0 references

1 reference

title

Enhanced analgesic activity by cyclodextrins - a systematic review and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26159048%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26159048%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Jullyana Quintans

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26159048%20AND%20SRC:MED&resulttype=core&format=json

Lucindo José Quintans Júnior

19 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26159048%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Kathleen Anne Sluka

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26159048%20AND%20SRC:MED&resulttype=core&format=json

Adriano Antunes de Souza AraÚjo

19 February 2020

2

object named as

Adriano A S Araújo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26159048%20AND%20SRC:MED&resulttype=core&format=json

Lucindo José Quintans Júnior

19 February 2020

6

object named as

Lucindo J Quintans-Júnior

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26159048%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

language of work or name

English

0 references

publication date

10 July 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26159048%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Delivery

19 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26159048%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26159048%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26159048%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

1677-1688

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26159048%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of chronic pain: a population-based nationwide study on its prevalence, characteristics and associated disability in Portugal.

19 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

The economic costs of pain in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Pharmacologic treatments for temporomandibular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Pain management: Part 1: Managing acute and postoperative dental pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

The science of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Translational investigation and treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Nonsteroidal anti-inflammatory drugs: a critical review on current concepts applied to reduce gastrointestinal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Cyclodextrins for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Piroxicam-β-cyclodextrin: a GI safer piroxicam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Cyclodextrins as encapsulation agents for plant bioactive compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Cyclodextrins in drug delivery: an updated review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Effects of piroxicam-beta-cyclodextrin sachets on abnormal postural sway in patients with chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

A randomized, double-blind, multicenter trial of nimesulide-beta-cyclodextrin versus naproxen in patients with osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

β-cyclodextrin complex containing Lippia grata leaf essential oil reduces orofacial nociception in mice - evidence of possible involvement of descending inhibitory pain modulation pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

β-Cyclodextrin-complexed (-)-linalool produces antinociceptive effect superior to that of (-)-linalool in experimental pain protocols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

In vivo bioavailability and therapeutic assessment of host-guest inclusion phenomena for the hydrophobic molecule etodolac: pharmacodynamic and pharmacokinetic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Etodolac/cyclodextrin formulations: physicochemical characterization and in vivo pharmacological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Antipyretic, analgesic and anti-inflammatory activities of ketoprofen beta-cyclodextrin inclusion complexes in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

In vivo efficacy of enabling formulations based on hydroxypropyl-β-cyclodextrins, micellar preparation, and liposomes for the lipophilic cannabinoid CB2 agonist, MDA7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Intrathecal neurosteroids and a neurosteroid antagonist: effects on inflammation-evoked thermal hyperalgesia and tactile allodynia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Improvement of tetracaine antinociceptive effect by inclusion in cyclodextrins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Sufentanil-2-hydroxypropyl-β-cyclodextrin inclusion complex for pain treatment: physicochemical, cytotoxicity, and pharmacological evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Transcutaneous electroporation mediated delivery of doxepin-HPCD complex: a sustained release approach for treatment of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Diclofenac: an update on its mechanism of action and safety profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Effects of nonsteroidal antiinflammatory drugs on patient-controlled analgesia morphine side effects: meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Non-steroidal anti-inflammatory drugs and spinal nociceptive processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Efficacy of non-steroidal anti-inflammatory drugs for low back pain: a systematic review of randomised clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Piroxicam-beta-cyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Nimesulide -- a multifactorial approach to inflammation and pain: scientific and clinical consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Evidence for the involvement of ionotropic glutamatergic receptors on the antinociceptive effect of (-)-linalool in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Evaluation of anti-inflammatory-related activity of essential oils from the leaves and resin of species of Protium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

p-Cymene protects mice against lipopolysaccharide-induced acute lung injury by inhibiting inflammatory cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Gastrointestinal toxicity, antiinflammatory activity, and superoxide dismutase activity of copper and zinc complexes of the antiinflammatory drug indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Regulation of osteogenic differentiation of human adipose-derived stem cells by controlling electromagnetic field conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Comparison of the effect of naproxen, etodolac and diclofenac on postoperative sequels following third molar surgery: a randomised, double-blind, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Comparative study of novel ultradeformable liposomes: menthosomes, transfersomes and liposomes for enhancing skin permeation of meloxicam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

In vitro effects of meloxicam on the number, Foxp3 expression, production of selected cytokines, and apoptosis of bovine CD25+CD4+ and CD25-CD4+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

The safety of ketoprofen in different ages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Effect of Different Carriers on in vitro Permeation of Meloxicam through Rat Skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Tablet formulation containing meloxicam and beta-cyclodextrin: mechanical characterization and bioavailability evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Mechanisms of neurosteroid interactions with GABA(A) receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Are neuroactive steroids promising therapeutic agents in the management of acute and chronic pain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Neurosteroids: endogenous role in the human brain and therapeutic potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

The cardiovascular effects and pharmacokinetics of intranasal tetracaine plus oxymetazoline: preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

The place for short-acting opioids: special emphasis on remifentanil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Doxepin in the Treatment of Primary Insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835

Effects of different doses of doxepin on passive avoidance learning in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.1046835